V004-3155 Screening compound: N-({1-[(3-methoxyphenyl)methyl]-4-phenylpyrrolidin-3-yl}methyl)-4-methyl-N-(2-methylpropyl)benzamide

V004-3155 Screening compound: N-({1-[(3-methoxyphenyl)methyl]-4-phenylpyrrolidin-3-yl}methyl)-4-methyl-N-(2-methylpropyl)benzamide
V004-3155 Screening compound: N-({1-[(3-methoxyphenyl)methyl]-4-phenylpyrrolidin-3-yl}methyl)-4-methyl-N-(2-methylpropyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V004-3155
N-({1-[(3-methoxyphenyl)methyl]-4-phenylpyrrolidin-3-yl}methyl)-4-methyl-N-(2-methylpropyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V004-3155

Molecular Formula

C31H38N2O2 (C31 H38 N2 O2)

Compound Name

N-({1-[(3-methoxyphenyl)methyl]-4-phenylpyrrolidin-3-yl}methyl)-4-methyl-N-(2-methylpropyl)benzamide

IUPAC name

N-({1-[(3-methoxyphenyl)methyl]-4-phenylpyrrolidin-3-yl}methyl)-4-methyl-N-(2-methylpropyl)benzamide

SMILES

CC(C)CN(CC(CN(Cc1cc(OC)ccc1)C1)C1c1ccccc1)C(c1ccc(C)cc1)=O

InChI

InChI=1S/C31H38N2O2/c1-23(2)18-33(31(34)27-15-13-24(3)14-16-27)21-28-20-32(19-25-9-8-12-29(17-25)35-4)22-30(28)26-10-6-5-7-11-26/h5-17,23,28,30H,18-22H2,1-4H3

InChI Key

LLKDNABYKWXPPT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19893409

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

470.65

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

6.289

Distribution Coefficient, logD

2.752

Water Solubility, LogSw

-5.41

Polar Surface Area

27.687

Acid Dissociation Constant (pKa)

23.12

Base Dissociation Constant (pKb)

10.94

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

38.70

V004-3155 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V004-3155 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V004-3155?
Check Price and Availability of V004-3155, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V004-3155 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V004-3155
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V004-3155
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V004-3155 available by request